Αρχική World News EMA Recommends Granting a Marketing Authorisation for Tarlatamab World News EMA Recommends Granting a Marketing Authorisation for Tarlatamab Από Ogkologos - 17 Απριλίου, 2026 361 0 Facebook Twitter Google+ Pinterest WhatsApp It is indicated for the treatment of adult patients with extensive-stage SCLC Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Nursing Professor Who Used Her Breast Cancer Diagnosis as a Teaching... 7 Δεκεμβρίου, 2020 How to Discuss Your Goals of Care With Your Cancer Care... 17 Οκτωβρίου, 2023 Navigating Life During and After Cancer As a Young Adult: A... 29 Νοεμβρίου, 2022 Suzanne Somers Discusses Her Cancer Diagnosis And Thinking Of Her ‘Mortality’ 6 Ιανουαρίου, 2020 Φόρτωση περισσοτέρων HOT NEWS Reduction Not Only in Recurrences, but Also in Mortality, Observed for... Cancer Research UK reports record levels of investment in its spinouts Hospital Lockdown Prevents Breast Cancer Patient from Receiving Treatment for 3... Five Questions with…Fred.